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Background: According to the World Health Organisation, influenza A (2009 pdmH1N1) has moved into the
post-pandemic phase, but there were still high numbers of infections occurring in the United Kingdom in
2010-11. It is therefore important to examine the burden of acute respiratory infections at a large children’s
hospital to determine pathogen prevalence, occurrence of co-infection, prevalence of co-morbidities and
diagnostic yield of sampling methods.
Methods: This was a retrospective study of respiratory virus aetiology in acute admissions to a paediatric
teaching hospital in the North West of England between 1st April 2010 and 31st March 2011. Respiratory
samples were analysed either with a rapid RSV test if the patient had symptoms suggestive of bronchiolitis,
followed by multiplex PCR testing for ten respiratory viruses, or with multiplex PCR testing alone if the patient
had suspected other ARI. Patient demographics and data regarding severity of illness, presence of
co-morbidities and respiratory virus sampling method were retrieved from case notes.
Results: 645 patients were admitted during the study period. 82/645 (12.7%) patients were positive for 2009
pdmH1N1, of whom 24 (29.2%) required PICU admission, with 7.3% mortality rate. Viral co-infection occurred in
48/645 (7.4%) patients and was not associated with more severe disease. Co-morbidities were present more
frequently in older children, but there was no significant difference in prevalence of co-morbidity between 2009
pdmH1N1 patients and those with other ARI. NPA samples had the highest diagnostic yield with 192/210
(91.4%) samples yielding an organism.
Conclusions: Influenza A (2009 pdmH1N1) is an ongoing cause of occasionally severe disease affecting both
healthy children and those with co-morbidities. Surveillance of viral pathogens provides valuable information on
patterns of disease.
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Acute respiratory infection (ARI) is an important cause
of death worldwide [1]. The recent influenza A (2009
pdmH1N1) pandemic contributed significantly to mor-
bidity and mortality from ARI [2]. In the 2009-10 sea-
son, the United Kingdom (UK) experienced 800,000
2009 pdmH1N1 infections and 457 deaths, and spent
£1.2 billion on treatment and prevention campaigns
[3]. In August 2010, the Director General of the World
Health Organisation declared that the virus was in the
post-pandemic phase and likely to be circulating for
years to come [4].
Despite weekly updates on the Public Health England
website about the numbers of circulating cases of influ-
enza and some other viruses [5], there is limited published
data on which respiratory viral pathogens cause ARI in
children in the UK. Our study has attempted to address
this knowledge gap by describing viral pathogen preva-
lence, occurrence of co-infection, diagnostic yield of sam-
pling methods and presence of co-morbidity in patients
with ARI caused by 2009 pdmH1N1 and other respiratory
viruses, in a large paediatric teaching hospital in the North
West of England over a year between April 2010 and
March 2011.
Methods
Setting and study design
This was a retrospective study of the case notes of patients
with suspected ARI who had respiratory samples sent for
rapid respiratory syncytial virus (RSV) testing and respira-
tory virus PCR analysis at Alder Hey Children’s NHS
Foundation Trust between 1st April 2010 and 31st March
2011. Diagnosis of ARI was based on clinical examination
by admitting doctor and case notes were reviewed to con-
firm coded diagnosis. Alder Hey is a large, university-
affiliated paediatric teaching hospital with a catchment
area of 7.5 million people and more than 270,000 patient
care episodes per annum, including 65,000 children seen
in the emergency department [6].
Subjects
Inclusion criteria
All children aged 0–16 years, symptomatic of ARI from
whom respiratory virus samples were taken, either at pres-
entation to hospital or within 7 days of admission. Patients
who had been admitted for surgery but developed PCR-
positive ARI within 7 days of admission were included, as
this time frame incorporates the incubation period for all
of the viruses studied [7-9]. Data for these patients are
highlighted as they were initially elective admissions and
thus may display different clinical characteristics to those
for whom ARI was the primary cause of admission. Data
was collected on clinical characteristics of the ARI includ-
ing: disease severity, presence of any co-morbidities andlength of hospital stay. Co-morbidities were recorded in
the categories of: haematology/oncology, respiratory, car-
diac, neurological, congenital/chromosomal and other (in-
cluding gastrointestinal and rheumatological conditions).
Exclusion criteria
Children from whom samples were taken more than
7 days after hospital admission, as it was considered that
these would be due to nosocomial rather than community-
acquired infection.
Definitions of disease severity:
Mild: No oxygen requirement
Moderate: Oxygen requirement but not requiring
admission to Paediatric Intensive Care unit (PICU)
Severe: Oxygen requirement and requiring admission
to PICU
Ethics statement
This study was approved as an audit by the IRB board at
the study hospital.
Pathogen detection
A number of sampling methods were used: nose/throat
(N/T) swabs, nasopharyngeal aspirate (NPA), endotracheal
aspirate (ETA), bronchoalveolar lavage (BAL) and sputum.
Remel MicroTest M4RT was the transport medium used
(Oxoid, Basingstoke, United Kingdom). The type of sam-
ple collected was at the discretion of clinical staff. Respira-
tory samples were analysed in one of two ways; either with
a rapid RSV test if the patient had symptoms suggestive of
bronchiolitis, followed by multiplex PCR testing for ten re-
spiratory viruses, or with multiplex PCR testing alone if
the patient had suspected other ARI.
RSV testing
This was completed on-site, using BinaxNOW RSV kit
(Alere Ltd, Stockport, United Kingdom) according to
the manufacturer’s instructions. The test is performed
on nasopharyngeal aspirates and detects RSV fusion
protein antigen.
Respiratory virus PCR analysis
The respiratory PCR screening assay comprises 5 multiplex
reactions detecting a total of 10 respiratory viruses. The
multiplex reactions detect influenza A (CDC published
protocol [10]) and influenza B, respiratory syncytial virus
and human metapneumovirus [11], adenovirus and human
rhinovirus [12], parainfluenza type 1, 2 and 3 and a specific
assay for the detection of the 2009 pdmH1N1 based on a
National Standard Method developed by the Health Protec-
tion Agency Microbiology Services. The 2009 pdmH1N1
assay was done if initial PCR was positive for influenza A.
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format by Life Technologies (Invitrogen, Paisley, United
Kingdom), and all other assays were performed with the
use of a SuperScript III Platinum one-step qRT-PCR kit
(Invitrogen) in a reaction volume of 30 μl. Thermal cycling
was carried out using a Life Technologies 7500 instrument
at 50°C for 30 minutes and at 95°C for 2 minutes, followed
by 45 cycles of denaturation at 95°C for 15 seconds and
annealing and extension at 60°C for 1 minute. Respira-
tory virus PCR assays were performed at the Public Health
Laboratory, Manchester. From December 2010 onwards,
assays for 2009 pdmH1N1 were performed on site at the
study hospital. A full evaluation of the method using a
range of titres for positive and negative controls and dual
testing of patient samples between the two centres was
undertaken prior to commencing the assays at the study
hospital to ensure comparable results between sites.
Statistical analysis
All results were analysed using Microsoft Excel 2010. Differ-
ences in outcomes were examined using Chi squared test,
with a p value <0.05 considered significant. Where data were
non-parametrically distributed, a Kruskal-Wallis test was
used.Results
Demographics and patient characteristics
The 645 admissions with ARI in this study represented 4% of
17,150 acute medical admissions between 1st April 2010 and
31st March 2011. Median (range; IQR) patient age was 0.9
(0–16; 0.3 – 3.3) years with 238/645 (36.9%) children being
< 1 year. 612/645 patients (94.9%) presented with suspected
acute respiratory infection and 33/645 (5.1%) became symp-
tomatic with ARI within seven days of admission for surgery.
Overall, 158/645 patients (24.5%) were classified as
having mild disease, 229/645 (35.5%) moderate and 258/
645 (40%) severe. Of those with ARI following surgery,
16/33 (48.5%) were mild, 2/33 (6%) moderate and 15/33
(45.5%) severe. Median (range; IQR) length of stay was 6
(0–339; 2–11) days and 369 patients (65.5%) with ARI
had a co-morbidity (see Figure 1). 21/645 (3.3%) patients
died during the study period.Types of respiratory sample
Six hundred and fifty-three respiratory samples were col-
lected from 645 children. Eight patients had repeat sam-
pling within 4 days of their original sample which detected
an additional respiratory virus. The most common sam-
pling methods used were NPA and N/T swab (Figure 2).
Of these, NPA samples had the highest diagnostic yield,
with a virus being detected in 192/210 (91.4%) samples
compared to 138/223 (61.9%) of N/T samples (P < 0.001).Pathogens causing ARI
A respiratory virus was detected in 503/653 samples (77%)
taken. 450/503 (89.5%) positive samples were taken within
48 hours of admission. Of these samples, 426/450 (94.7%)
were taken within the first 24 hours of admission.
The commonest organism detected was RSV (found
in 196/503 (39%) positive samples), followed by 2009
pdmH1N1 (82/503; 16.3%) and hRV (human rhinovirus)
(79/503; 15.7%). Co-infection occurred in 48/645 patients
(7.4%) (Table 1). The pathogen most commonly identified in
co-infections was adenovirus; co-infection was detected in
24/49 patients with adenovirus (20 dual, 3 triple and 1 quad-
ruple co-infection). RSV and 2009 pdmH1N1 co-infection
occurred in 9 cases (Additional file 1). Co-infection was not
associated with disease severity; percentages of patients with
mild, moderate and severe disease were comparable for in-
fection with 1 versus 2 viruses (28%, 39% and 33% respect-
ively compared to 28%, 37% and 33%). PICU admission was
significantly more likely to occur in patients with PCR-
negative samples (110/196; 56%) than those in whom 1
(132/401; 33%), 2 (15/43; 35%) or 3 (0/4; 0%) viruses were
detected (p < 0.001).
2009 pdmH1N1 infection
2009 pdmH1N1 infection was detected in 82/645 chil-
dren (12.7%), with median (range; IQR) patient age 1.3
(0.1-15; 0.6 – 3.5) years and 37/82 (45.1%) children be-
ing under 1 year of age.
Median (range; IQR) length of stay for admissions with
2009 pdmH1N1 infection was 4 days (0–56; 2–11), in
comparison to 6 days for all other admissions studied (0–
339; 3–11 days). Disease severity was classed as mild in
30/82 (36.6%) 2009 pdmH1N1 patients, moderate in 28/
82 (34.1%), and severe in 24/82 (29.2%) cases. As expected,
patients with severe disease had significantly longer me-
dian hospital stay (12.5 days), than patients who only re-
quired general medical ward care (3 days) (p = 0.02). The
median (range; IQR) length of time spent in PICU for
2009 pdmH1N1 patients was 5.5 days (1–54; IQR 3–16).
Prevalence of co-morbidities in patients with 2009
pdmH1N1 infection
Figure 1 shows the prevalence of different co-morbidities
in children infected with 2009 pdmH1N1, versus those
who had any other respiratory virus and PCR-negative pa-
tients based on age.
In children < 1 yr, the prevalence of co-morbidities was
similar (2009 pdmH1N1 32%, other respiratory virus 32%,
PCR-negative 41%), with congenital cardiac and respira-
tory (most frequently chronic lung disease of prematurity)
conditions being most prevalent across the three groups.
In children aged 1-5 yrs, 2009 pdmH1N1 patients had
the lowest incidence of existing co-morbidities (55%),
compared to those with other respiratory virus (61%) and
Figure 1 Co-morbidities in 2009 pdmH1N1 admissions versus admissions positive for other viruses or PCR-negative (PCR-N).
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Figure 2 Percentage of positive samples by sampling method.
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and respiratory conditions were the most frequent co-
morbidities across all admissions.
In children aged 5-12 yrs, co-morbidities were very com-
mon, with patients with other respiratory viruses having the
highest frequency of co-morbidities (86%), followed by
2009 pdmH1N1 (75%) and PCR-negative (61%) (p < 0.05).
Neurological co-morbidities were again common across
all groups, with the highest incidence occurring in 2009
pdmH1N1 admissions. Haematology/oncology conditions
were also common in both 2009 pdmH1N1 and admis-
sions with other respiratory viruses.
In >12 yr olds, co-morbidities were again very frequent
overall, being found in 85% PCR-negative and 89% other
respiratory virus admissions. 2009 pdmH1N1 admissions
had the lowest rate of co-morbidity here (50%) (p > 0.05).Table 1 Pathogens detected in single and co-infections durin
Pathogen No. single
infections
No
in
Adenovirus 25
Influenza A (non-2009 pdmH1N1) 4
Influenza A 2009 pdmH1N1 69
Influenza B 30
Human metapneumovirus 21
Parainfluenza 1 4
Parainfluenza 2 1
Parainfluenza 3 15
Human rhinovirus 64
Respiratory syncytial virus 168
Total 401As with the 5-12 yr cohort, neurological conditions were
frequent in all groups with haematological/oncological con-
ditions again being common in 2009 pdmH1N1 and pa-
tients with other respiratory viruses.
Overall, co-morbidities became more prevalent with in-
creasing age of the patient, but there was no significant differ-
ence in levels of co-morbidity between patients with 2009
pdmH1N1, other respiratory virus and PCR-negative patients.
Disease severity in relation to infecting virus
There was a significant difference in mortality between RSV
admissions (1%; 2/196 patients) and 2009 pdmH1N1 admis-
sions (7.3%; 6/82 patients) (p < 0.01). Mortality rates during
the period studied were 4.6% for PCR-negative admissions (9/
196 patients) and 5.1% for influenza B (2/39 patients). There
were no fatalities with non-2009 pdmH1N1 influenza A.g the study period
. occurrences
co-infections
Total no.
occurrences
% occurrences
as co-infector
24 49 49.0
3 7 42.9
13 82 15.9
9 39 23.1
5 26 19.2
1 5 25.0
0 1 0
4 19 21.1
15 79 19.0
28 196 14.3
102 503
Figure 3 Percentage prevalence of disease severity for each pathogen.
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For RSV, moderate disease was most common. For 2009
pdmH1N1, mild disease was most common, and for
PCR-negative patients and those with hRV, severe dis-
ease was most common (p < 0.05) (Figure 3).
Seasonality of viruses 2010/11
Post-pandemic 2009 pdmH1N1 seasonality in 2010–11
was very well defined, with all cases (excepting 2 noted in
November) occurring during December 2010 and January
2011 (Figure 4).Figure 4 Seasonality of viruses, showing number of cases of each viruDiscussion
In this study, 2009 pdmH1N1 caused a spectrum of illness
varying from mild to severe disease with mortality both in
previously healthy children and those with co-morbidities.
Viral co-infection was found in a small proportion of cases
and did not appear to be associated with severe disease. We
found the prevalence of co-morbidities to be least in
children <1 year old, whether infected with 2009 pdmH1N1
or not. Generally, the presence of co-morbidities was more
frequent in older cohorts. In younger children, cardiac and
respiratory conditions tended to be most frequent, withs per month from April 2010-March 2011.
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ing more prevalent in older children.
A study from Birmingham, UK describing experiences
during the first wave of 2009 pdmH1N1 cases in 2009 found
that 31/77 (40%) patients admitted and all 6 patients who
required HDU/ICU care had significant co-morbidities [9].
Similar findings have been reported in a number of other
countries [13-16]. In the UK, a study of influenza deaths in
2009–10 by Public Health England found that children with
co-morbidities had a higher case fatality rate when infected
with 2009 pdmH1N1 compared to seasonal influenza [2]. In
our study, two thirds of 2009 pdmH1N1 patients who died
had significant co-morbidities, in keeping with UK national
data [17].
At the start of the pandemic in August 2009, it was pre-
dicted that 3.8% of hospitalised 2009 pdmH1N1 patients
under 15 yrs in the UK would require PICU admission
[18]. Data published subsequently on the first 2009
pdmH1N1 ‘wave’ showed that 7.7% of infected patients in
Birmingham, UK [13], 4.8% in Turin, Italy [15] and 19% in
Buenos Aires, Argentina [19] required PICU admission.
Mortality rate amongst those with 2009 pdmH1N1 infec-
tion in the Argentinean study was 5%, with the majority
occurring in patients under 1 year. In contrast, this group
in our study had a 2.7% mortality rate, with overall mortal-
ity of 7.3% for all 2009 pdmH1N1 admissions.
In our institution, 29% of patients in whom 2009
pdmH1N1 was detected required PICU admission, with
median length of stay of 5.5 days. This very high rate
may reflect the direct transfer of 2009 pdmH1N1-
infected patients into our PICU from other hospitals, as
it is a large regional centre. However, this would not ac-
count for all of the variation; other causes could include
the high number of children with complex medical
needs who are under the care of the hospital, a shortfall
in HDU beds associated with the 2009 pdmH1N1 pan-
demic leading to direct PICU admission, or improved
virological surveillance of PICU patients leading to a
2009 pdmH1N1 diagnosis.
In our study, Adenovirus was the most common or-
ganism found in co-infections; however, co-infection
rates in our study were very low compared with inter-
national data [20]. This disparity with other studies is
likely due in large part to social, environmental and cli-
matic differences between countries. Recent studies have
found adenovirus and bocavirus particularly common in
co-infections [21]. Both these viruses persist in respira-
tory secretions for weeks to months, so it is difficult to
ascertain whether the presence of these pathogens is due
to acute infection or viral persistence within the respira-
tory tract [20].
We did not find a convincing link between presence of
viral co-infection and severity of illness. In fact, PCR-
negative patients had the highest rates of PICU admission,suggesting that these patients had bacterial rather than
viral illnesses. There appears to be no current consensus
on whether viral co-infection is associated with disease se-
verity [22,23]. Of those with ARI following surgery, a com-
parable proportion to those who attended with suspected
ARI were classified as severe. There were however more
mild cases in the post-surgical group, who may not other-
wise have been hospitalised. In our study, we found that
NPA samples had a much higher diagnostic yield for virus
detection compared to other sampling methods. This is in
keeping with the findings of Chan et al. [24] who found
NPA to be the optimal specimen type for diagnosis of viral
ARI. However, de la Tabla et al. [25] found N/T swabs to
have a higher diagnostic yield, with a combination of both
methods providing the highest sensitivity. It is likely that
the diagnostic yield for NPAs was so high in our study be-
cause most were taken to detect RSV during the bron-
chiolitis ‘season’ when the ‘hit’ rate was likely to be
highest.
Limitations of study
We were unable to collect information on bacterial culture
during the study; this information would have been valu-
able in assessing whether severe disease in PCR-negative
patients, or those with hRV was due to an underlying bac-
terial infection. We also do not have data on viral load for
viruses detected, which could have helped to differentiate
between infection and asymptomatic shedding. This study
gathered data over the space of one year, incorporation of
data from the previous and following years could have
provided information on fluctuation of circulating viruses.
This is a single site study; however there is no reason to
suspect that Liverpool would differ from other UK cities
in terms of circulating pathogens. It would have been use-
ful to record influenza immunisation status of admissions,
as this may have influenced individuals’ susceptibility to
influenza infection and likelihood of hospitalisation.
This study elucidates aspects of ARI experience in the
UK, but an unexpected strength is that it raises discus-
sion on current cohorting practices for inpatients. Re-
spiratory viral diagnosis is recommended for all
hospitalised infants in order to ascertain disease aeti-
ology and allow optimal use of isolation cubicles to pre-
vent nosocomial infection. Importantly, we have shown
that a wide range of viral single infections and co-
infections occurred in patients with RSV-negative ARI
who would not necessarily have been isolated or
cohorted, increasing risk of nosocomial transmission to
other patients on the ward [22]. Rapid multiplex respira-
tory virus testing allows early identification of non-RSV
single and co-infections in real time, and enables more
effective isolation and cohorting strategies to reduce
nosocomial respiratory virus transmission, and allow
better utilisation of cubicles.
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Our study found 2009 pdmH1N1 to be the second most
common circulating viral pathogen (after RSV) in all pa-
tients admitted with suspected ARI between April 2010 and
March 2011. Patients with 2009 pdmH1N1 frequently re-
quired PICU admission and mortality rates were signifi-
cantly higher for 2009 pdmH1N1 disease than RSV. Co-
morbidities in admitted patients became more prevalent
with increasing age.
This study confirms influenza A 2009 pdmH1N1 in-
fection as an ongoing cause of occasionally severe
disease affecting both healthy children and those with
co-morbidities.Additional file
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